Full Research Papers
Review Articles
2023
Kamankesh M, Yadegar A, Llopis-Lorente A, Liu C, Haririan I, Aghdaei HA, Shokrgozar MA, Zali MR, Miri AH, Rad-Malekshahi M, Hamblin MR, Wacker MG.
Future Nanotechnology-Based Strategies for Improved Management of Helicobacter pylori Infection
Small. 2023 Sep 11:e2302532. doi: 10.1002/smll.202302532. Online ahead of print.
2022
Miri AH, Kamankesh M, Llopis-Lorente A, Liu C, Wacker MG, Haririan I, Asadzadeh Aghdaei H, Hamblin MR, Yadegar A, Rad-Malekshahi M, Zali MR.
The Potential Use of Antibiotics Against Helicobacter pylori Infection: Biopharmaceutical Implications
Front Pharmacol. 2022 Jun 27;13:917184. doi: 10.3389/fphar.2022.917184. eCollection 2022.
Other Publications
Workshops, Expert Opinions, Book Chapters
2017
Wacker MG
Nanomedicines – A Scientific Toy or an Emerging Market? in Polymer nanoparticles for Nanomedicines: A Guide for Design, Preparation and Development
Editor(s): Christine Vauthier, Gilles Ponchel, In Polymer Nanoparticles for Nanomedicines: A Guide for their Design, Preparation and Development, Springer, 2017, Pages 623-651, ISBN 3319414208
2020
Hermans A, Dorozynski P, Muzzio FJ, Li H, Nielsen S, Chen S, Reppas C, Klein S, Patel S, Wacker M, Thakker K, Pruessmann K, Seidlitz A, Ghosh TK, Yang Y, Willett D, Hochhaus G, Tay J, Liew CV, Heng PWS, Sun CC, Kraemer J, Marques MRC
Workshop Report: USP Workshop on Advancements in In Vitro Performance Testing of Drug Products
Diss Tech 2020 May 8; 27(2) 52-70. doi: 10.14227/DT270220P52
2018
Wacker MG, Janas C, Ferreira FS, Vieira FP
Chapter 21 - Manufacturing and Safety Guidelines for Manufactured Functionalized Nanomaterials in Pharmaceutics
Editor(s): Bruno Sarmento, José das Neves, In Micro and Nano Technologies, Biomedical Applications of Functionalized Nanomaterials, Elsevier, 2018, Pages 623-651, ISBN 9780323508780
2015
Wacker M
Suspensionen – Parenteralia, Ophthalmika und perorale Suspensionen: Teilchengrößen-wachstum, Stabilität, Freisetzung
Editor(s): Frank Stieneker, In Partikel in der Pharmaproduktion: Messtechnik – Detektion und Charakterisierung – Regulatorische Anforderungen, ECV, 2016
More Science
Latest Talks, Posters, Abstracts
2024-06
Wacker MG
Computational Biopharmaceutics: Exploring the Drug Delivery Lifecycle of Complex Injectables
DISSO India 2023
Ahmedabad, India
Plenary talk
2023-06
Wacker MG
Biopredictive Tools for Injectables: Long-Acting and Long-Circulating Systems
DISSO 2023
Mumbai, India
Plenary talk
2022-11
Wacker MG
Biopredictive Strategies for Injectables: Tomorrow’s In Vitro-In Silico Toolkit
12th Fresenius Global Preclinical Meeting
Germany
Plenary talk (Virtual)
2022-07
Wacker MG
Nanomedicine Ex Machina: Design Strategies Based on Clinical Relevance
Fraunhofer IAP Seminars
Potsdam, Germany
Invited talk
2022-02
Wacker MG
Evolution of Dissolution Technologies for Novel Dosage Forms
Dissolution Discussion Group webinar
India
Invited talk (Virtual)
2021-09
Wacker MG
Translational Nanomedicine: Biopredictive Tools For Drug Product Development
2nd International Symposium on Drug Delivery Systems
Brazil
Plenary talk (Virtual)
2021-07
Wacker MG
Nanomedicines Revisited: A Facelift For Personalized Therapy?
20th Asian Conference on Clinical Pharmacy
Singapore
Invited talk (Virtual)
2021-04
Modh H
IVIVR for Injectable Nanomedicines – Standing on the Shoulders of Giants
2nd ExplainMyResearch Conference
Singapore
Invited talk (Virtual)
2020-09
Nagpal S, Modh H, Wacker MG
Simulating kinetics of liposomal prednisolone phosphate using physiologically based nano-carrier biopharmaceutics model
AAPS-NUS Student Chapter NUS-Monash Conference
Singapore
Invited talk (Virtual)
2020-06
Wallenwein CM
A dialysis-based in vitro drug release assay to study dynamics of the drug-protein transfer of temoporfin liposomes
SPDS Disso Research Presentations India 2020 Online
India
Invited talk (Virtual)
2020-02
Wacker MG
Translational Nanotechnology – Performance Assays for the Next Generation, CRS Local Chapter India
CRS Local Chapter India
Mumbai, India
Plenary talk
2019-06
Jung F, Thurn M, Krollik K, Gao FG, Hering I, Eilbrecht E, Weiler M, Günday-Türeli N, Türeli E, Parnham MJ, Wacker MG
Simulation of the environmental exposure to fenofibrate nanomaterials based on in vitro- and in silico methods
PAGE Conference
Stockholm, Sweden
Poster abstract
2018-06
Gao F, Villa Nova M, Ashtikar M, Wacker MG
Prediction of human pharmacokinetics of subcutaneously administered depot formulation using MBPK modeling
PAGE conference
Montreux, Switzerland
Post abstract
2018-03
Wacker MG
Challenges in the drug release testing of next-generation nanomedicines
CRS Indian Chapter Meeting
Mumbai, India
Plenary talk
2016-11
Jablonka L, Thurn M, Wacker MG
In vitro drug release testing of liposomal temoporfin formulations with the dispersion releaser technology
GPEN Meeting
Lawrence, USA
Poster abstract
2016
Wacker MG
Challenges in the Drug Release Testing of Next-Generation Nanomedicines
NanoBioMedizin Meeting
Frankfurt, Germany
Plenary talk
2016
Wacker MG
Designing Nanocarriers For Drug Delivery
NRW-Nanokonferenz
Münster, Germany
Plenary talk
2024-06
Wacker MG
Computational Biopharmaceutics: Exploring the Drug Delivery Lifecycle of Complex Injectables
DISSO America 2024
Newark, USA
Plenary talk
2023-05
Wacker MG
Novel Complex Dosage Forms in Drug Delivery: Do We Need A New Biopredictive Toolbox?
PSTS 2023
Singapore
Invited talk
2022-10
Wacker MG
Injectable Nanomedicines: Biopredictive Release Testing and IVIVC
12th Global Summit on Regulatory Science
Singapore
Invited talk
2022-06
Wacker MG
Biopredictive Tools for Injectable Dosage Forms
Global Drug Delivery & Formulation Summit
Berlin, Germany
Plenary talk
2021-11
Wacker MG
Translational Nanomedicine: Crossing Borders in Drug Delivery
Nano Singapore 2021 conference and exhibition
Singapore
Keynote lecture (Virtual)
2021-09
Wacker MG
Novel dosage forms (part II): Parenteral products
3rd SOTAX Congress
Switzerland
Invited talk (Virtual)
2021-04
Wacker MG
Nanomedicines Revisited: A Facelift For Personalized Therapy?
2nd ExplainMyResearch Conference
Singapore
Keynote lecture (Virtual)
2020-11
Wacker MG
Nanomedicine at the crossroads: Why good chemistry is not enough
Beilstein Talks
Germany
Invited talk (Virtual)
2020-09
Wacker MG
Nanomedicine Unleashed – Case Studies on Performance Testing
AAPS-NUS Student Chapter NUS-Monash Virtual Event
Singapore
Keynote lecture (Virtual)
2020-05
Jung F
Nanoparticles and Environmental Protection – A Gordian Knot?; ExplainMyResearch Conference
ExplainMyResearch Conference
Singapore
Invited talk (Virtual)
2019-12
Wacker MG
Dissolution of drug products containing nanomaterials
USP workshop
Rockville, USA
Invited talk
2019-06
Gao FG, Villa Nova M, Ashtikar M, Wacker MG
Prediction of human pharmacokinetics of subcutaneously administered insulin formulations
PAGE conference
Stockholm, Sweden
Poster abstract
2018-06
Jung F, Nothnagel L, Gao F, Wacker MG
Evaluation of release techniques for nanocarriers on the basis of IVIVC-PBPK modeling
PAGE conference
Montreux, Switzerland
Poster abstract
2018-02
Wacker MG
Advances in Nanosized Drug Delivery – Lost in Translation?
LOSAN Drug Delivery Conference
Frankfurt, Germany
Invited talk
2016-11
Nothnagel L, Thurn M, Wacker MG
DoE-based development and in vitro drug release testing of TMP-001 loaded nanocarriers
GPEN Meeting
Lawrence, USA
Poster abstract
2016
Wacker MG
Assessing the drug release from nanocarriers: when, why and how?
PT Indonesia Workshop
Jakarta, Indonesia
Invited talk
2016
Wacker MG
Assessing the drug release from nanocarriers: when, why and how?
LOSAN Drug Delivery Conference
Frankfurt, Germany
Invited talk
2024-05
Wacker MG
Computational Biopharmaceutics: Biopredictive Technologies in the Nanomedicine Design Space
Transporter and Barrier Days
Bad Herrenalb
Oral abstract
2023-02
Wacker MG
Nanotech meets Data Science: Biopredictive Methods in Drug Delivery
PharmNotts Industrial Talk 2023
Malaysia
Invited talk (Virtual)
2022-07
Wacker MG
Nanomedicine Ex Machina: Design Strategies Based on Clinical Relevance
Goethe Graduate Academy for Early Career Researchers Seminars
Frankfurt, Germany
Invited talk
2022-05
Wacker MG
Nanomedicine Ex Machina: Design Strategies Based on Clinical Relevance
13th European and Global Summit for Nanomedicine
Switzerland
Invited talks
2021-11
Wacker MG
Biopredictions in NanoMedicine: Understanding Clinical Data
Annual Meeting of the German Platform NanoBioMedicine
Germany
Plenary talk (Virtual)
2021-09
Wacker MG
Biopredictive Tools for the Development of Injectable Drug Products
11th American Drug Delivery and Formulation Summit
USA
Plenary talk (Virtual)
2021-04
Nagpal S
High-Throughput Nanoformulation Development – A QbD-Based Approach
2nd ExplainMyResearch Conference
Singapore
Invited talk (Virtual)
2020-10
Wacker MG
Nanomedicines today: Quality by Design or Trial and Error?
12th European and Global Summit for Nanomedicine
Switzerland
Invited talk (Virtual)
2020-06
Wacker MG
Nanomedicine in the Spotlight – Unlock your PK
APTI Virtual Seminar
India
Plenary talk (Virtual)
2020-05
Wacker MG
Nanomedicine 2020 – Tiny Giants Unleashed; 1st ExplainMyResearch Conference
1st ExplainMyResearch Conference
Singapore
Invited talk (Virtual)
2019-09
Wacker MG
Translational Nanomedicine – How to predict clinical performance?
Global Summit on Regulatory Science
Stresa, Italy
Plenary talk
2019-03
Wacker MG
Theranostic nanocarriers loaded with nerve growth factor enable enhanced brain recovery after stroke
European Conference on Pharmaceutics
Bologna, Italy
Oral abstract
2018-06
Wacker MG
Nanotechnology in translation – Define, design, produce!
Institute of Materials and Environmental Chemistry/Hungarian Academy of Sciences
Budapest, Hungary
Invited talk
2017-10
Wacker MG
Safety & Regulatory Aspects of Nanomedicines
National University of Singapore Workshop
Singapore
Invited talk
2016-03
Wacker MG
Designing Nanomedicines for the Market
7th Global Drug Delivery and Formulation Summit
Berlin, Germany
Plenary talk
2016
Wacker MG
Assessing the drug release from nanocarriers: when, why and how?
Matrix Analytical Technologies Workshop
Kuala Lumpur, Malaysia
Invited talk